Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
IC50 (functional) | > 40 ug ml-1 | Antiviral activity against cytomegalovirus (CMV) Davis strain in HEL cell culture | ChEMBL. | 8831773 |
IC50 (functional) | = 40 ug ml-1 | Antiviral activity in TK+ varicella zoster virus (VZV) OKA strain in HEL cell culture | ChEMBL. | 8831773 |
IC50 (functional) | = 40 ug ml-1 | Antiviral activity in TK+ varicella zoster virus (VZV) YS strain in HEL cell culture | ChEMBL. | 8831773 |
IC50 (functional) | > 40 ug ml-1 | Antiviral activity in TK+ varicella zoster virus (VZV) 07/1 strain in HEL cell culture | ChEMBL. | 8831773 |
IC50 (functional) | = 40 ug ml-1 | Antiviral activity in TK+ varicella zoster virus (VZV) YS/R strain in HEL cell culture | ChEMBL. | 8831773 |
IC50 (functional) | > 40 ug ml-1 | Compound was tested for anti-retroviral activity against moloney murine sarcoma virus (MSV) in murine C3H/3T3 embryo fibroblast cell culture | ChEMBL. | 8831773 |
IC50 (functional) | > 100 ug ml-1 | Antiviral activity against cytomegalovirus (CMV) AD169 strain in HEL cell culture | ChEMBL. | 8831773 |
IC50 (functional) | > 100 ug ml-1 | Inhibition of human immunodeficiency virus-1 (HIV-1) induced cytopathicity in human MT-4 cells | ChEMBL. | 8831773 |
IC50 (functional) | > 100 ug ml-1 | Inhibition of human immunodeficiency virus-1 (HIV-1) induced cytopathicity in CEM cells | ChEMBL. | 8831773 |
IC50 (functional) | > 100 ug ml-1 | Inhibition of human immunodeficiency virus-2 (HIV-2) induced cytopathicity in MT-4 cells | ChEMBL. | 8831773 |
IC50 (functional) | > 100 ug ml-1 | Inhibition of human immunodeficiency virus-2 (HIV-2) induced cytopathicity in CEM cells | ChEMBL. | 8831773 |
IC50 (functional) | > 100 ug ml-1 | Inhibition of human immunodeficiency virus-2 (HIV-2) induced cytopathicity in MT-4 cells | ChEMBL. | 8831773 |
IC50 (functional) | = 150 ug ml-1 | Antiviral activity against vaccinia virus (VV) in E6SM cell culture | ChEMBL. | 8831773 |
IC50 (functional) | > 300 ug ml-1 | Antiviral activity against thymidine kinase deficient herpes simplex virus-1 HSV-1 TK- VMW-1837 strain in E6SM cell culture | ChEMBL. | 8831773 |
IC50 (functional) | > 300 ug ml-1 | Antiviral activity inherpes simple virus-2 (HSV-2) Lyons strain in E6SM cell culture | ChEMBL. | 8831773 |
IC50 (functional) | > 400 ug ml-1 | Antiviral activity against herpes simplex virus-1 KOS in E6SM cell culture | ChEMBL. | 8831773 |
IC50 (functional) | > 400 ug ml-1 | Antiviral activity against thymidine kinase deficient herpes simplex virus-1 HSV-1 TK- B2006 strain in E6SM cell culture | ChEMBL. | 8831773 |
IC50 (functional) | > 400 ug ml-1 | Antiviral activity in herpes simplex virus-2 (HSV-2) G strain in E6SM cell culture | ChEMBL. | 8831773 |
IC50 (functional) | > 400 ug ml-1 | Antiviral activity inherpes simplex virus-2 (HSV-2) 196 strain in E6SM cell culture | ChEMBL. | 8831773 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.